Today, NESTcc announced 12 new Real-World Evidence (RWE) Test-Cases. These projects will answer questions of importance to the medical device ecosystem through collaborations between NESTcc Network Collaborators and submitting organizations, including health systems, government organizations, non-profit patient organizations, and medical device manufacturers. NESTcc’s Test-Case portfolio now includes 20 projects that span the Total Project Life Cycle (TPLC); leverage multiple data sources including device registries, electronic health records (EHR), claims, and patient-generated health data (PGD); and include technologies of interest across 9 disease areas and along the 510(k) and premarket approval regulatory pathways. Included in these new projects are the first Test-Cases to utilize patient-generated health data (PGD), the first active surveillance project, and the project in response to a question submitted from a patient advocacy organization.
Read the full Press Release, including a full overview of NESTcc’s projects and collaborating organizations, here.